Yazar "Ozcan, Berna Ersoy" seçeneğine göre listele

Listeleniyor 1 - 3 / 3
  • [ X ]
    Öğe
    Levels of intolerance of uncertainty, rumination and resilience among healthcare workers during the Covid-19 pandemic
    (Cukurova Univ, Fac Medicine, 2021) Aydin, Adeviye; Ozcan, Berna Ersoy
    Purpose: The aim of this study is to examine the levels of intolerance of uncertainty, rumination and resilience among healthcare workers during the COVID-19 pandemic. Materials and Methods: This descriptive and cross-sectional study was conducted with 310 healthcare workers. Data were collected using an Introductory Information Form, the Intolerance of Uncertainty Scale, the Ruminative Thought Style Questionnaire and the Brief Resilience Scale. Results: In this study, it was found that ruminative thinking style was lower in healthcare workers aged 37 years and over and with more experience, and higher in shift workers. As a result of multiple linear regression analysis, it was determined that intolerance to uncertainty and psychological resilience have a significant effect on ruminative thinking style. Intolerance of uncertainty and resilience explained 38.5% of the total variance in rumination, and both variables were identified as significant predictors of rumination. Conclusion: The levels of intolerance of uncertainty and rumination among healthcare workers can be reduced by closely monitoring the working conditions and mental states of the workers and developing programs to protect the workers from potential negative psychological effects and to improve their resilience.
  • [ X ]
    Öğe
    The Effect of an Emotion Recognition and Expression Program on the Alexithymia, Emotion Expression Skills and Positive and Negative Symptoms of Patients with Schizophrenia in a Community Mental Health Center
    (Taylor & Francis Inc, 2024) Aydin, Adeviye; Ozcan, Berna Ersoy; Kaya, Yunus
    This study aimed to examine the effect of an emotion recognition and expression program (EREP) on the alexithymia, emotion expression skills and positive and negative symptoms of patients with schizophrenia. The study had a non-randomized, quasi-experimental design including a pretest, post-test, and follow-up test. It was conducted with 36 patients with schizophrenia (n = 18 intervention group, n = 18 control group) who regularly visited a Community Mental Health Center (CMHC) in Turkiye and participated voluntarily. The EREP was applied to the intervention group for eight weeks. Personal Information Form, Emotion Expression Scale (EES), Toronto Alexithymia Scale (TAS), and Positive Negative Syndrome Scale (PANSS) were applied to all participants in the pretest, post-test, and follow-up test. The follow-up test was applied one month after the end of the sessions. Number, percentage, chi-square test, and repeated measures analysis of variance were used for data evaluation. In the total alexithymia score, there was a significant difference in the group interaction by time in the intervention group compared to the control group. In terms of total alexithymia score, the post-test and follow-up test mean scores of the intervention group were lower than the control group (p < 0.05; eta 2 = 0.122). There was a significant time*group interaction in the positive emotion subscale of the EES (p < 0.05; eta 2 = 0.121). The findings of our study indicated that the EREP had a positive effect on the alexithymia scores of patients with schizophrenia. We found that the EREP used in our study contributed to the reduction of alexithymia levels in patients with schizophrenia.
  • [ X ]
    Öğe
    The Effects of Hopelessness and Some Variables on Metabolic Syndrome in Schizophrenia Patients
    (Sage Publications Inc, 2022) Durmaz, Yadigar Cevik; Menekli, Tugba; Ozcan, Berna Ersoy
    This is a descriptive study conducted to determine the prevalence of Metabolic Syndrome (MetS) in Schizophrenia patients and identify the effects of hopelessness and some variables on MetS. The study was conducted at the Psychiatry Clinic of a university hospital in Turkey between May and August 2020 with 105 schizophrenia patients receiving treatment as inpatients. The data of the study were collected by a Personal Information Form, a Physiological Measurements Form and (BHS). The data were analyzed by using SPSS 25. The mean age of the patients was 35.31 +/- 9.07, their mean duration of disease was 11.35 +/- 9.07 years, and 60.0% of the patients were using atypical antipsychotics as their latest drug treatment. 42.9% of the patients had MetS, while the mean hopelessness level of those with MetS was 10.84 +/- 3.81. It was determined that hopelessness levels and some sociodemographic (age) and clinical variables significantly predicted the MetS status in the schizophrenia patients.